Abstract
As vulvar and vaginal cancers are rare malignancies, treatment is extrapolated from the cervical cancer field, in which concurrent chemoradiation is used. Thus, further studies are necessary to evaluate whether surgery, radiotherapy (RT) or combined chemoradiotherapy (CRT) will benefit patients the most.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have